Psychemedics Corp.  

(Public, NASDAQ:PMD)   Watch this stock  
Find more results for PMD
-0.33 (-2.14%)
Jan 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 15.06 - 15.56
52 week 12.42 - 18.76
Open 15.06
Vol / Avg. 10,379.00/6,982.00
Mkt cap 80.22M
P/E 23.77
Div/yield 0.15/3.98
EPS 0.63
Shares 5.38M
Beta 0.81
Inst. own 49%
Jan 15, 2015
Psychemedics Corp at Needham Growth Conference
Oct 30, 2014
Q3 2014 Psychemedics Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 11.90% 14.16%
Operating margin 16.15% 21.24%
EBITD margin - 24.48%
Return on average assets 15.95% 24.81%
Return on average equity 28.90% 32.39%
Employees 151 -
CDP Score - -


Suite 200, 125 Nagog Park
ACTON, MA 01720
United States - Map
+1-800-6288073 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. The Company�s testing methods utilize a technology to enzymatically dissolve hair samples and then perform radioimmunoyassays on the hair sampled, with confirmation testing by mass spectrometry. Its primary application of its technology is as a testing service that analyzes hair samples for the presence of certain drugs of abuse. Its tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time providing superior detection compared to other types of drug testing. It provides commercial testing and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, phencyclidine (PCP), methamphetamine and opiates. Testing services are performed at its laboratory in Culver City, California.

Officers and directors

Raymond C. Kubacki Jr. Chairman of the Board, President, Chief Executive Officer
Age: 69
Bio & Compensation  - Reuters
Neil L. Lerner Vice President - Finance, Treasurer
Age: 46
Bio & Compensation  - Reuters
Michael I. Schaffer Ph.D. Vice President - Laboratory Operations
Age: 69
Bio & Compensation  - Reuters
James V. Dyke Corporate Vice President - Sales and Marketing
Age: 49
Bio & Compensation  - Reuters
Harry F. Connick Sr. Independent Director
Age: 88
Bio & Compensation  - Reuters
Walter S. Tomenson Independent Director
Age: 67
Bio & Compensation  - Reuters
Fred J. Weinert Independent Director
Age: 66
Bio & Compensation  - Reuters